Systemic hyperthermia and ICE chemotherapy for sarcoma patients: Rationale and clinical status

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 2899-2902

  Wiedemann, Gunter J ^a   Robins, H Ian ^b,c   Katschinski, D M ^a   Mentzel, Martin ^a   D'Oleire, Floriane ^d   Kutz, Matthew ^b   Wagner, Thomas ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d NONE

Author keywords

Sarcoma; Whole body hyperthermia

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART OUTPUT; HEART RATE; HUMAN; HYPERTHERMIA; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; SARCOMA; SYSTOLIC BLOOD PRESSURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; HUMANS; HYPERTHERMIA, INDUCED; IFOSFAMIDE; SARCOMA;

EID: 0030864814     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Wiedemann G, Mella O, Roszinski S, Weis C and Wagner T: Hyperthermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice. Int J Radiat Oncol Biol Phys 24: 669-673, 1992.
2. Wiedemann GJ, Roszinsk S, Biersack A, Weiss C and Wagner T: Local hyperthermia enhances cyclophosphamide, if osfamide, and cisdiamminedichloroplatinum (II) cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. J Cancer Res Clin Oncol 118: 129-135, 1992.
3. Wiedemann GJ, Siemens HJ, Mentzel M, Biersack A, Wossmann W, Knocks D, Weiss C and Wagner T: Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. Cancer Res 53: 4268-4272, 1993.
4. Cohen JD, Robins HI and Schmitt CL: Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide. Cancer Letters 44: 205-210, 1989.
5. Cohen JD and Robins HI: Thermal enhancement of tetraplatin and carboplatin in human leukemia cells in vitro. Int J Hyperthermia 6: 1013-1017, 1990.
6. Tapazoglou E, Cohen J, Khatana A, Schmitt CL, Sapareto SA and Robins HI: Whole body hyperthermia and carboplatin: cytotoxicity for murine leukemia and normal marrow. Brit J Cancer 64: 528-530, 1991.
7. Robins HI, d'Oleire F, Kutz M, Bird A, Schmitt-Tiggelaar CL, Cohen JD and Spriggs DR: Cytotoxic interactions of tumor necrosis factor, melphalan, and 41.8 °C hyperthermia. Cancer Letters 89: 52-62, 1995.
8. d'Oleire F, Kutz M, Bird A and Robins H: Step down heating and melphalan: Cytotoxicity interactions and clinical implications. Melanoma Research 4: 303-305, 1994.
9. Cohen JD, Robins HI and Javid M: Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine. J Neurooncol 9: 1-8, 1990.
10. Ohno D, Siddik ZH, Baba H, Stephens C, Strebel FR, Wondergem J, Khokhar AR and Bull JMC: Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 51: 2994-3000, 1991.
11. Robins HI, Kutz M, Wiedemann G, Paul D, Katschinski DM, Grosen E, Tiggelaar CL, Spriggs D, Gillis W and d'Oleire F: Cytokine induction by 41.8°C whole body hyperthermia. Cancer Letters 97: 195-201, 1995.
12. Wallner KE, DeGregorio MW and Li GC: Hyperthermic potentiation of cisdiamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells. Cancer Res 46: 6242-6245, 1986.
13. Robins HI, Jonsson GG, Jacobson EL, Schmitt CL, Cohen JD, and Jacobson MK: Effect of hyperthermia in vitro and in vivo on adenine and pyridine nucleotide pools in human peripheral lymphocytes. Cancer 67: 2096-2102, 1991.
14. Robins HI, Neville AJ and Cohen JD: Whole body hyperthermia: biological, and clinical aspects. Clinical Thermology, ed. M. Gautherie. Germany: Springer-Verlag Berlin Heidelberg. 1992.
15. Wallner KE, Banda M and Li GC: Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Res 47: 1308-1312, 1987.
16. Chatterjee S, Cheng M, Berger S and Berger N: Induction of Mr 78,000 glucose regulated stress protein in poly(adenosine diphosophate-ribose) polymerase- and nicotinamide adenine dinucleotide deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide. Cancer Res 54: 4405-4411, 1994.
17. Woods JP, Schmitt CL, Rosenthal RC, d'Oleire F and Robins HI: Canine bone marrow as a potential thermal sanctuary during the plateau phase of 41.8°C whole body hyperthermia. Int J Hyperthermia 11: 49-57, 1995.
18. d'Oleire F, Robins HI, Cohen JD, Schmitt CL and Spriggs D: Cytokine induction in humans by 41.8°C whole body hyperthermia. J. Natl. Cancer Inst 85: 833-834, 1993.
19. Mentzel M Katschincki D, Wiedemann G, Wagner T and Rohins H: Ifosfamide carboplatin and etoposide (ICE) combined with 41.8 °C whole hody hyperthermia. Anticancer Res 15(6A): 2448 abs #192, 1995.
20. Wiedemann GJ, d'Oleire F, Knop E, Eleftheriadis S, Bucsky P, Feddersen S, Klouche M, Geisler J, Mentzel M, Schmucker P, Feyerabend T, Weiss C and Wagner T: Ifosfamide and Carboplatin combined with 41.8 °C Whole-body Hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res 54: 5346-5350, 1994.
21. Wiedemann G, Robins H, Gutsche S, Mentzel M, Deeken M, Katschinski DM, Eleftheriadis S, Crahe R, Weiss C, Storer B and Wagner T: Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 °C whole-body hyperthermia in patients with refractory sarcoma. Eur J Cancer 32A: 888-892, 1996.
22. Robins HI, Cohen JD, Schmitt CL, Tutsch KD, Feierabend C, Arzoomanian RZ, Alberti D, d'Oleire F, Longo W, Heiss C, Rushing D and Spriggs D: Phase I clinical trial of carboplatin and 41.8°C whole body hyperthermia in cancer patients. J Clin Oncol 11: 1787-1794, 1993.
23. Fields K, Zorsky P, Hiemenz J, Kronish L and Elfenbein G: Ifosfamide, carboplatin and etoposide: A new regimen with a broad spectrum of activity. J Clin Oncol 12: 544-552, 1994.
24. Robins HI, Schmitt-Tiggelaar CL, Cohen JD, Woods JP, Heiss C, Gillis W, d'Oleire F: A new technological approach to radiant heat whole body hyperthermia. Cancer Letters 79: 137-145, 1994.
25. Robins HI: Meeting Report: Systemic Hyperthermia Oncological Working Group. Oncology - Int J Cancer Res Treat 52(3): 260-263, 1995.
26. Katschinski DM, Wiedemann GJ, Mentzel M, Mulkerin DL, Touhidi R, Robins HI: Optimization of chemotherapy administration for clinical 41.8°C whole body hyperthermia. Cancer Letters 115: 195-199, 1997.